Our data revealed that Pbrm1 loss synergized with oncogenic Kras and heterozygous or homozygous Trp53 deletion to form poorly differentiated PDAC or undifferentiated pancreatic carcinoma with squamous subtype properties. The gene discussed is PBRM1; the disease is exocrine pancreatic carcinoma.